Global, regional, and national burden of stroke, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016.
GBD 2016 Stroke Collaborators
https://pubmed.ncbi.nlm.nih.gov/30871944Actively Recruiting
Led by University Hospital, Grenoble · Updated on 2025-02-11
1620
Participants Needed
1
Research Sites
260 weeks
Total Duration
Researchers are studying the occurrence of major heart and brain-related events in patients after their first stroke, first transient ischemic attack (TIA), or recurrent TIA. This research compares patients with sleep-disordered breathing (SDB) to those without SDB one year after diagnosing SDB three months post-stroke. The primary focus is on a combined measure of serious cardiac or brain events including death, non-fatal stroke, and acute coronary disease. The study includes 1620 patients aged 18 to 85 who are in the acute phase of a stroke or TIA and have low disability before the event. Patients will be grouped based on polysomnography results performed three months after their stroke or TIA to diagnose SDB, defined by an apnea-hypopnea index higher than 15 events per hour. Those with SDB will receive treatment according to standard care, such as Continuous Positive Airway Pressure (CPAP), mandibular advancement devices, positional therapy, adaptive servo-ventilation, or non-invasive ventilation. The study follows patients over five years, with assessments at enrollment, three months, and annually after SDB diagnosis. Participants undergo detailed clinical, imaging, cognitive, sensorimotor, and biological evaluations at various points, including stroke imaging, blood sampling, and questionnaires on quality of life, depression, and sleep. Regular follow-up assesses new cardiac or cerebrovascular events, stroke-related outcomes, treatment adherence, and cognitive and functional abilities. An ancillary study focuses on patients eligible for carotid surgery, evaluating plaque changes and molecular markers. The primary outcome measure is collected one year after SDB diagnosis, with long-term monitoring continuing up to five years.
CONDITIONS
Apnea, Stroke and Incident Cardiovascular Events
You may qualify if you...
You will not qualify if you...
Complete this quick 3-step screening to check your eligibility
Duration - Up to 3 days
Participants are screened for eligibility to participate in the trial.
1 visit (in-person) within 72 hours after stroke symptoms
Duration - From Day 1 to 6 months after stroke
Participants undergo clinical history review, clinical evaluation, anthropometrical measurements, stroke-related assessments, functional, cognitive, and sensorimotor evaluations, walking and locomotion tests, questionnaires, stroke MRI imaging, and blood sampling.
1 to multiple visits during inclusion period
Duration - At 3 months after stroke
Participants undergo polysomnography to diagnose sleep-disordered breathing and repeat clinical, MRI, and biological assessments, as well as questionnaires.
1 visit (in-person) for polysomnography and assessments
Duration - From diagnosis and ongoing as per clinical indication
Participants diagnosed with sleep-disordered breathing receive treatment according to standard care recommendations, including CPAP, mandibular advancement device, positional therapy, adaptive servo-ventilation, or non-invasive ventilation.
Treatment adherence and tolerance monitored during follow-up visits
Duration - Initial 3 months and then annually up to 5 years after sleep apnea diagnosis
Participants are followed for neurological and sleep outcomes including assessment of new cardiac or cerebrovascular events, stroke-related parameters, questionnaires, functional, cognitive and sensorimotor evaluations, locomotion tests, and sleep treatment adherence and efficacy monitoring. Biological sampling is also performed.
Multiple visits: initial 3 months of clinical follow-up plus annual visits up to 5 years
Duration - From baseline (carotid surgery) through 5 years after sleep apnea diagnosis
Participants eligible for carotid surgery undergo additional assessments including carotid stenosis and artery wall thickness measurements, plaque analysis during surgery, and miRNA analyses in plasma, urine, and carotid plaque.
Visits at inclusion, 3 months, 6 months, and annually up to 5 years
Total: 1 location
1
University Hospital Grenoble
Grenoble, France, 38043
Actively Recruiting
S
Sébastien Baillieul, MD, MSc
S
Sara Saadi, MSc
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
GBD 2016 Stroke Collaborators
https://pubmed.ncbi.nlm.nih.gov/30871944Shahrokh Javaheri, Ferran Barbe, Francisco Campos-Rodriguez...
https://pubmed.ncbi.nlm.nih.gov/28209226Dirk M Hermann, Claudio L Bassetti
https://pubmed.ncbi.nlm.nih.gov/27488603Andrea Seiler, Millene Camilo, Lyudmila Korostovtseva...
https://pubmed.ncbi.nlm.nih.gov/30635478Lynda D Lisabeth, Brisa N Sánchez, David Lim...
https://pubmed.ncbi.nlm.nih.gov/31155749Anne-Kathrin Brill, Thomas Horvath, Andrea Seiler...
https://pubmed.ncbi.nlm.nih.gov/29523641Pierre Amarenco, Philippa C Lavallée, Julien Labreuche...
https://pubmed.ncbi.nlm.nih.gov/27096581Pierre Amarenco, Philippa C Lavallée, Linsay Monteiro Tavares...
https://pubmed.ncbi.nlm.nih.gov/29766771Joanna M Wardlaw, Miriam Brazzelli, Francesca M Chappell...
https://pubmed.ncbi.nlm.nih.gov/26136519Joseph P Broderick, Opeolu Adeoye, Jordan Elm
https://pubmed.ncbi.nlm.nih.gov/28626052